Hormone Replacement Therapy for the Primary Prevention of Chronic Diseases ()

View original publication


  • Given the balance of harms and benefits, the Canadian Task Force on Preventive Health Care (CTFPHC) recommends against the use of combined estrogen–progestin therapy and estrogen-only therapy for the primary prevention of chronic diseases in menopausal women.

    (grade D recommendation)
  • For women who wish to alleviate menopausal symptoms using hormone replacement therapy (HRT), a discussion between the woman and her physician about the potential benefits and risks of HRT is warranted.